Careers

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2025 HSCA National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Congressional Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2025 HSCA National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Congressional Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HEALTHCARE SUPPLY CHAIN ASSOCIATION JOINS END DRUG SHORTAGE ALLIANCE TO SAFEGUARD ACCESS TO ESSENTIAL MEDICATIONS

October 12, 2022 by Grace Crozier 2022 Press Releases, Press Releases 0 comments

Washington, DC (October 12, 2022) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of healthcare’s more pressing and enduring issues, drug shortages that disrupt patient care.

“Healthcare GPOs are critical partners helping hospitals and the healthcare system avert and mitigate the impact of drug shortages and have helped reduce the number of shortages by half over the last decade. The Healthcare Supply Chain Association is proud to join the End Drug Shortage Alliance alongside many of our member GPOs and looks forward to working with the coalition to identify durable solutions to drug shortages and protect patient access to care,” said HSCA President and CEO Todd Ebert.

The End Drug Shortages Alliance was launched in late 2021 to bring together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors, and other industry thought leaders and champions. Efforts will focus on improving access to medications through greater transparency across market participants, leading to improved quality manufacturing of medications and production of additional supply. Learn more at EndDrugShortages.com.

Click here to read the full release.

Prev
Next

Related Posts

Joint Letter of Support for Swift Action on the MEDS Act
February 28, 2020

Dear Chairman Alexander and Ranking Member Murray, As the United...

Learn more
HSCA Statement on President Biden’s Executive Order on the Healthcare Supply Chain
January 22, 2021

HSCA Statement on President Biden’s Executive Order on the Healthcare Supply...

Learn more
HSCA Statement on President Biden’s Executive Order on America’s Supply Chains
February 25, 2021

Washington, DC (February 25, 2021) – Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Releases Fourth Annual Report On Value GPOs Deliver To The Healthcare Supply Chain
June 4, 2021

Washington, DC (June 4, 2021) – The Healthcare Supply Chain Association (HSCA),...

Learn more

Our Office

Healthcare Supply Chain Association
750 9th Street NW, Suite 650
Washington, DC 20001

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Response to the U.S. Department of Commerce’s Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
    May 8, 2025
  • HSCA Response to the U.S. Trade Representative’s Request for Comments on Unfair and Non-Reciprocal Foreign Trade Practices
    March 12, 2025